May 10~ Hotel Inter-Burgo Exco, Daegu Plenary lectures From metabolic syndrome to diabetes Meta-inflammation responsible for the progression fr

Similar documents
Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

20Â÷ ´ç´¢ÇÐȸ ¾È³»¼�

A 617

±¹¹®½áŧ·¯c00μâ¿ëœ302÷

Invitation 안녕하십니까? 2011 년신묘년새해를맞아회원여러분의가정과병원에건강과행운이가득하시길기원합니다. 대한당뇨병학회에서는 2011 년 5 월 12 일부터 14 일까지광주김대중컨벤션센터에서제 24 차대한당뇨병 학회춘계학술대회를개최하고자합니다. 이번학술대회에서는

(Microsoft PowerPoint - S13-3_\261\350\273\363\307\366 [\310\243\310\257 \270\360\265\345])

Microsoft PowerPoint - CNVZNGWAIYSE.pptx

서론 34 2

untitled

2019_2nd_guide_kr_0619.indd


Risk of Developing Hypertension by Daily Intake of Alcohol

황지웅

심장2.PDF

00약제부봄호c03逞풚


레이아웃 1

본발표와관련된이해관계 없음 대한당뇨병학회학술위원회


<3034C0D3BBF3C3E1B0E8C7D0BCFABCBCB9CCB3AA2E687770>

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

<4D F736F F F696E74202D20BAD0B4E7B3BBB0FABFACBCF6B0ADC1C F66696E616C2E BC8A3C8AF20B8F0B5E55D>

2009¿©¸§È£ÃÖÁ¾

27 2, 17-31, , * ** ***,. K 1 2 2,.,,,.,.,.,,.,. :,,, : 2009/08/19 : 2009/09/09 : 2009/09/30 * 2007 ** *** ( :

사회동향-내지간지수정

ºñ¸¸1Àå

185

*199호_전체

186최종

197

ecorp-프로젝트제안서작성실무(양식3)

DIABETES FACT SHEET IN KOREA 2012 SUMMARY About 3.2 million Korean people (10.1%) aged over 30 years or older had diabetes in Based on fasting g

000표지

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할

인문사회과학기술융합학회

(Microsoft PowerPoint - CXBTUEOAPVQY.ppt [\310\243\310\257 \270\360\265\345])

7.ƯÁýb71ÎÀ¯È« š

<C6F7B7B320BAEAB7CEBCC55FC0DAB7E1C1FDBFEB E706466>

untitled

2014밝고고운동요부르기-수정3

2005프로그램표지

0729경영학회 브로셔 2_17.ps, page Normalize ( 경영학회 브로셔 2_17 )

½Å³âÈ£-Ç¥Áö

여름호-내지원본

V28.


DBPIA-NURIMEDIA

페링야간뇨소책자-내지-16

00_( ) 당뇨춘계_2014_목차1.hwp

歯1.PDF

?

歯3이화진

,,,,,,, ,, 2 3,,,,,,,,,,,,,,,, (2001) 2

170

006- 5¿ùc03ÖÁ¾T300çÃâ

γ

I care - Do you?

07_À±¿ø±æ3ÀüºÎ¼öÁ¤

1

( )Kju269.hwp

27 2, 1-16, * **,,,,. KS,,,., PC,.,,.,,. :,,, : 2009/08/12 : 2009/09/03 : 2009/09/30 * ** ( :

사회동향1-2장

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Analysis of


자식농사웹완

chungo_story_2013.pdf

*중1부

2

Çѱ¹ÀÇ ¼º°øº¥Ã³µµÅ¥

...._



전반부-pdf

표1.4출력

003-p.ps

<4D F736F F F696E74202D20312E20B0E6C1A6C0FCB8C15F3136B3E2C7CFB9DDB1E25F325FC6ED28C0BA292E >

_

12월월간보고서내지편집3

중앙도서관소식지겨울내지33

에너지포커스 2007년 가을호


01_당선자공약_서울

인권문예대회_작품집4-2




목차

A°ø¸ðÀü ³»Áö1-¼öÁ¤

±¹³»°æÁ¦ º¹»ç1

¿¡³ÊÁö ÀÚ¿ø-Âü°í ³»Áö.PDF

전반부-pdf

뉴스레터6호

Microsoft PowerPoint 하반기 크레딧 전망_V3.pptx

50차 본문 최종

양성내지b72뼈訪?303逞

³»Áöc03âš

fsb9¿ù³»ÁöÃÖÁ¾Ãâ

¾ç¼º-¾÷¹«Æí¶÷-³»¿ëÃà¼Ò4

전도대회자료집


Transcription:

May 10~12 2012 Hotel Inter-Burgo Exco, Daegu Plenary lectures From metabolic syndrome to diabetes Meta-inflammation responsible for the progression from obesity to metabolic syndrome originates in the endoplasmic reticulum stressed tissues Symposia S1 Clinical diabetes & therapeutics 1 S2 Epidemiology & genetics S3 Islet biology & insulin secretion S4 Education S5 Diabetic complications 1 S6 Insulin resistance S7 Obesity S8 Self care S9 Clinical diabetes & therapeutics 2 S10 Clinical diabetes & therapeutics 3 S11 Diabetic complications 2 S12 Nutrition Joint symposium In-depth symposium Meet the experts POCT (point of care testing), a step to future Basic and clinical approach of gestational DM Diabetes in elderly Korean www.diabetes.or.kr

CONTENTS Invitation 01 Timetable 02 03 Plenary lecture 03 Symposia 04 Satellite symposia 14 Social program 16 Registration 17 Poster presentation & exhibition 18 Floor plan 19 Transportation 20 Accommodation 21

Invitation INVITATION 1

Time table TIME TABLE 2

Plenary lecture 1 From metabolic syndrome to diabetes Plenary lecture 2 Meta-inflammation responsible for the progression from obesity to metabolic syndrome originates in the endoplasmic reticulum stressed tissues 3

Joint symposium Therapeutic modalities to correct mitochondrial dysfunction-ksmcb mitochondrial section & KSMRM joint symposium 4

In-depth symposium Adipokines in diabesity S1 Clinical diabetes & therapeutics 1 Hypoglycemia in diabetes treatment 5

S2 Epidemiology & genetics Updates on genetics in diabetes S3 Islet biology & insulin secretion Regulation of islet generation, function and survival 6

S4 Education Metabolic syndrome S5 Diabetic complications 1 Current status and management of macrovascular disease in Korea 7

S6 Insulin resistance MicroRNA regulation on insulin resistance S7 Obesity Recent advances in the pathogenesis of obesity 8

S8 Self care Goal oriented diabetes self management education (DSME) strategy 9

S9 Clinical diabetes & therapeutics 2 Debate session 1 - Role of bariatric surgery in less obese diabetic patients Debate session 2 - Which one is primary in the pathogenesis of type 2 diabetes in Korea; insulin resistance vs. insulin secretion defect? S10 Clinical diabetes & therapeutics 3 Current issues in diabetes treatment 10

S11 Diabetic complications 2 A novel mechanism in diabetic vascular complications S12 Nutrition Salt, hypertension, diabetes and prevention 11

Meet the experts Management of diabetes in the adolescents POCT (point of care testing), a step to future 12

Basic and clinical approach of gestational DM Diabetes in elderly Korean 13

Satellite symposia Satellite symposium 1 Clinical experience with sitagliptin in Korean subjects with type2 diabetes Satellite symposium 2 New clinical experience of gemigliptin Breakfast symposia Breakfast symposium 1 What is the optimal insulin treatment when the patient is not adequately controlled with basal insulin? Breakfast symposium 2 Can we reduce CV complication by targeting normal glucose levels? Breakfast symposium 3 Why do we need another the DPP-4 inhibitors? Breakfast symposium 4 Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients 14

Luncheon symposia Luncheon symposium 1 Optimizing diabetic dyslipidemia beyond traditional risk factors: is there a microvascular benefit? Luncheon symposium 2 What are the advantages of ONGLYZA(saxagliptin) for the treatment of type 2 diabetes mellitus? Luncheon symposium 3 The new reliable options to treat dyslipidemia with diabetes mellitus Luncheon symposium 4 Evidences demonstrating the effects of anti-atherosclerotic actions of pioglitazone in T2DM patients Luncheon symposium 5 Management of diabetic peripheral neuropathy Luncheon symposium 6 Insulin treatment strategies by new clinical trials Luncheon symposium 7 Efficacy and safety of sitagliptin in various clinical settings of type 2 diabetes 15

Social program SOCIAL PROGRAM Welcome reception Opening address Young investigator award Dinner Closing & award ceremony 16

Registration REGISTRATION 17

Poster presentation & exhibition POSTER PRESENTATION & EXHIBITION 18

Floor plan FLOOR PLAN 19

Transportation TRANSPORTATION 20

Accommodation ACCOMMODATION 21

Deadline for registration: 26 September 2012 Deadline for abstract submission: 31 August 2012